Cambridge Innovation Capital (CIC) has today launched a new £100 million Opportunity Fund to invest in growth stage deep tech and life sciences companies.
With up to £20 million per investment into later-stage rounds of deep tech and life sciences companies, the Opportunity Fund aims to address the UK’s scale-up financing gap, which forces many of Britain’s most promising companies to seek overseas funding to support their growth. Developing home-grown global technology businesses is a central theme of the Government’s plans to create Europe’s Silicon Valley, with Cambridge at the heart of the transformation.
The fund has already made its first two investments – into chip designers and manufacturer Pragmatic Semiconductor and quantum error correction company Riverlane.
The fund has received significant backing from Aviva Investors and British Patient Capital and the potential returns available from the UK’s maturing scale-up ecosystem.
Full story: Cambridge Innovation Capital launches £100M Fund for deeptech and life sciences – Tech.eu
